Hudson Bay Capital Management
CEROW

Hudson Bay Capital Management’s CERo Therapeutics Warrants CEROW Stock Holding History

Hudson Bay Capital Management’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,400
Closed -$1.04K – 1023
2022
Q4 		$1.04K Hold
26,400
– – ﹤0.01% 964
2022
Q3 		$4K Sell
26,400
-3,600
-12% -$303 ﹤0.01% 1170
2022
Q2 		$3K Hold
30,000
– – ﹤0.01% 1301
2022
Q1 		$6K Hold
30,000
– – ﹤0.01% 1165
2021
Q4 		$13K Buy
+30,000
New +$13.8K ﹤0.01% 1062

Other funds holding CEROW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 76.63% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 28.97% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 26.7% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 12.96% 1-Year Est. Return

Hudson Bay Capital Management's CEROW Position: Q1 2023 in Review

Hudson Bay Capital Management sold out of CERo Therapeutics Warrants (CEROW) in Q1 2023, closing a stake of 26,400 shares — an estimated $1.04K sold.

Hudson Bay Capital Management first reported a position in CEROW in Q4 2021 and held it in 5 quarters. The position peaked at $13K in Q4 2021. 46 funds tracked by Wall St. Rank hold CEROW as of Q1 2023.

  • Hudson Bay Capital Management reported no remaining CERo Therapeutics Warrants position as of Q1 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 26,400 CERo Therapeutics Warrants shares in Q1 2023, an estimated $1.04K.
  • Hudson Bay Capital Management first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 5 quarters.
  • Hudson Bay Capital Management's CERo Therapeutics Warrants position peaked at $13K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q1 2023.

Based on Hudson Bay Capital Management's 13F filing for Q1 2023, filed 15 May 2023.